Orchestra BioMed Holdings, Inc. logo

Orchestra BioMed Holdings, Inc.

NASDAQ:OBIO

Overview | Financials
Company Name Orchestra BioMed Holdings, Inc.
Symbol OBIO
Currency USD
Price 8.03
Market Cap 287,381,655
Dividend Yield 0%
52-week-range 4.22 - 11.69
Industry Biotechnology
Sector Healthcare
CEO Mr. David P. Hochman
Website https://orchestrabiomed.com

An error occurred while fetching data.

About Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical

Related Stocks

Financials

Numbers are in millions USD

Numbers are in millions USD